Known targets — ChEMBL curated mechanism
ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4
The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTO1 | P78417 | 2/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.62 |
| ▸ | TTPA | P49638 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.62 |
| ▸ | PDE4A | P27815 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.57 |
| ▸ | AKT1 | P31749 | 3/20 | 0.56 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.56 |
| ▸ | PHLPP1 | O60346 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL708028 | 0.94 | LMNA (0.64) | GSTO1PTPN1LMNAMAPTMEN1 | |
| SCHEMBL2695150 | 0.93 | LMNA (0.71) | GSTO1PTPN1LMNAMAPTMEN1 | |
| SCHEMBL14695837 | 0.93 | LMNA (0.71) | GSTO1PTPN1LMNAMAPTMEN1 | |
| SCHEMBL39202 | 0.93 | LMNA (0.71) | GSTO1PTPN1LMNAMAPTMEN1 | |
| SCHEMBL3460249 | 0.93 | LMNA (0.71) | GSTO1PTPN1LMNAMAPTMEN1 | |
| SCHEMBL17874902 | 0.93 | LMNA (0.71) | GSTO1PTPN1LMNAMAPTMEN1 | |
| Phosphoric Acid SCHEMBL8652705 | 0.90 | GSTO1 (0.65) | GSTO1PTPN1LMNAMAPTMEN1 | |
| Phosphoric Acid SCHEMBL20917308 | 0.90 | GSTO1 (0.65) | GSTO1PTPN1LMNAMAPTMEN1 | |
| Alcohol SCHEMBL28691903 | 0.90 | LMNA (0.67) | GSTO1PTPN1LMNAMAPTMEN1 | |
| Benzoquinone SCHEMBL1187748 | 0.89 | LMNA (0.63) | GSTO1PTPN1LMNAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107669632-B | Drug carrier, micelle, drug preparation, preparation method and application thereof | 四川大学 | 2021-07-02 | — | — | CN | claimed |
| CN-112220752-A | Micelle and preparation method and application thereof | 四川大学 | 2021-01-15 | — | — | CN | claimed |
| US-9801913-B2 | Barrier layer | ATRIUM MEDICAL CORPORATION (US) | 2017-10-31 | — | — | US | claimed |
| US-8821568-B2 | Implant modified with non-hydroxylated vitamin D precursors | NUMAT BIOMEDICAL S.L. (ES) | 2014-09-02 | — | — | US | claimed |
| US-8795703-B2 | Stand-alone film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2014-08-05 | — | — | US | claimed |
| US-8367099-B2 | Perforated fatty acid films | ATRIUM MEDICAL CORPORATION (US) | 2013-02-05 | — | — | US | claimed |
| US-20130017234-A1 | IMPLANT MODIFIED WITH NON-HYDROXYLATED VITAMIN D PRECURSORS | NUMAT BIOMEDICAL S.L. (ES) | 2013-01-17 | — | — | US | claimed |
| WO-2010104786-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | ATRIUM MEDICAL CORPORATION (US) | 2010-09-16 | — | — | WO | claimed |
| US-20100233231-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | ATRIUM MEDICAL CORPORATION | 2010-09-16 | — | — | US | claimed |
| EP-2086605-A2 | PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME | Atrium Medical Corporation (US) | 2009-08-12 | — | — | EP | claimed |
| WO-2008039308-A2 | PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2008-04-03 | — | — | WO | claimed |
| EP-1812022-A2 | STAND-ALONE FILM AND METHODS FOR MAKING THE SAME | Atrium Medical Corporation (US) | 2007-08-01 | — | — | EP | claimed |
| US-20070071798-A1 | Perforated bioabsorbable oil film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2007-03-29 | — | — | US | claimed |
| US-20060088596-A1 | Solubilizing a drug for use in a coating | ATRIUM MEDICAL CORPORATION (US) | 2006-04-27 | — | — | US | claimed |
| US-20060083768-A1 | Method of thickening a coating using a drug | ATRIUM MEDICAL CORPORATION (US) | 2006-04-20 | — | — | US | claimed |
| WO-2006036984-A2 | STAND-ALONE FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| WO-2006036970-A2 | METHOD OF THICKENING A COATING USING A DRUG | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| WO-2006036967-A1 | SOLUBILIZING A DRUG FOR USE IN A COATING | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| US-20060067983-A1 | Stand-alone film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | claimed |
| CN-118240890-A | Method for preparing natural high-purity beta-tocopherol monomer from low-value material | 山东新元素生物科技有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118240890-A | Method for preparing natural high-purity beta-tocopherol monomer from low-value material | 山东新元素生物科技有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-11793912-B2 | Cross-linked fatty acid-based biomaterials | ATRIUM MEDICAL CORPORATION (US) | 2023-10-24 | — | — | US | disclosed |
| US-11166929-B2 | Fatty-acid based particles | ATRIUM MEDICAL CORPORATION (US) | 2021-11-09 | — | — | US | disclosed |
| CN-106890366-B | Biomaterials based on cross-linked fatty acids | 埃特瑞姆医疗公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-107669632-B | Drug carrier, micelle, drug preparation, preparation method and application thereof | 四川大学 | 2021-07-02 | — | — | CN | disclosed |
| US-20210030928-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2021-02-04 | — | — | US | disclosed |
| CN-112220752-A | Micelle and preparation method and application thereof | 四川大学 | 2021-01-15 | — | — | CN | disclosed |
| US-10869902-B2 | Cured gel and method of making | ATRIUM MEDICAL CORPORATION (US) | 2020-12-22 | — | — | US | disclosed |
| US-10814043-B2 | Cross-linked fatty acid-based biomaterials | ATRIUM MEDICAL CORPORATION (US) | 2020-10-27 | — | — | US | disclosed |
| US-10792312-B2 | Barrier layer | ATRIUM MEDICAL CORPORATION (US) | 2020-10-06 | — | — | US | disclosed |
| US-10772995-B2 | Cross-linked fatty acid-based biomaterials | ATRIUM MEDICAL CORPORATION (US) | 2020-09-15 | — | — | US | disclosed |
| US-20200171213-A9 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2020-06-04 | — | — | US | disclosed |
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-05-14 | — | — | US | disclosed |
| EP-3603571-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | Atrium Medical Corporation (US) | 2020-02-05 | — | — | EP | disclosed |
| US-10285964-B2 | Fatty-acid based particles | ATRIUM MEDICAL CORPORATION (US) | 2019-05-14 | — | — | US | disclosed |
| US-20190054053-A1 | FATTY-ACID BASED PARTICLES | ATRIUM MEDICAL CORPORATION (US) | 2019-02-21 | — | — | US | disclosed |
| EP-2348844-B1 | CROSS- LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORP (US) | 2019-01-09 | — | — | EP | disclosed |
| WO-2018218281-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-12-06 | — | — | WO | disclosed |
| US-20180200306-A1 | CURED GEL AND METHOD OF MAKING | ATRIUM MEDICAL CORPORATION (US) | 2018-07-19 | — | — | US | disclosed |
| US-10016465-B2 | Cured gel and method of making | ATRIUM MEDICAL CORPORATION (US) | 2018-07-10 | — | — | US | disclosed |
| US-20180050132-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2018-02-22 | — | — | US | disclosed |
| US-20180043065-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2018-02-15 | — | — | US | disclosed |
| US-20180008650-A1 | BARRIER LAYER | ATRIUM MEDICAL CORPORATION (US) | 2018-01-11 | — | — | US | disclosed |
| US-9827352-B2 | Cross-linked fatty acid-based biomaterials | ATRIUM MEDICAL CORPORATION (US) | 2017-11-28 | — | — | US | disclosed |
| US-9827353-B2 | Cross-linked fatty acid-based biomaterials | ATRIUM MEDICAL CORPORATION (US) | 2017-11-28 | — | — | US | disclosed |
| US-9801913-B2 | Barrier layer | ATRIUM MEDICAL CORPORATION (US) | 2017-10-31 | — | — | US | disclosed |
| US-9801982-B2 | Implantable barrier device | ATRIUM MEDICAL CORPORATION (US) | 2017-10-31 | — | — | US | disclosed |
| US-9682175-B2 | Coating material and medical device system including same | ATRIUM MEDICAL CORPORATION (US) | 2017-06-20 | — | — | US | disclosed |
| US-9592324-B2 | Tissue separating device with reinforced support for anchoring mechanisms | ATRIUM MEDICAL CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |
| US-9492596-B2 | Barrier layer with underlying medical device and one or more reinforcing support structures | ATRIUM MEDICAL CORPORATION (US) | 2016-11-15 | — | — | US | disclosed |
| US-20160324816-A1 | FATTY-ACID BASED PARTICLES | ATRIUM MEDICAL CORPORATION (US) | 2016-11-10 | — | — | US | disclosed |
| EP-2626091-B1 | Coated surgical mesh | ATRIUM MEDICAL CORP (US) | 2016-09-28 | — | — | EP | disclosed |
| US-9427423-B2 | Fatty-acid based particles | ATRIUM MEDICAL CORPORATION (US) | 2016-08-30 | — | — | US | disclosed |
| EP-1811935-B1 | HEAT CURED GEL AND METHOD OF MAKING | ATRIUM MEDICAL CORP (US) | 2016-03-30 | — | — | EP | disclosed |
| EP-1811933-B1 | BARRIER LAYER | ATRIUM MEDICAL CORP (US) | 2016-03-23 | — | — | EP | disclosed |
| US-9220820-B2 | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings | ATRIUM MEDICAL CORP (US) | 2015-12-29 | — | — | US | disclosed |
| EP-2136784-B1 | BIO-ABSORBABLE OIL SUSPENSION | ATRIUM MEDICAL CORP (US) | 2015-11-04 | — | — | EP | disclosed |
| US-20150224233-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2015-08-13 | — | — | US | disclosed |
| US-20150209482-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2015-07-30 | — | — | US | disclosed |
| US-9012506-B2 | Cross-linked fatty acid-based biomaterials | ATRIUM MEDICAL CORPORATION (US) | 2015-04-21 | — | — | US | disclosed |
| US-9000040-B2 | Cross-linked fatty acid-based biomaterials | ATRIUM MEDICAL CORPORATION (US) | 2015-04-07 | — | — | US | disclosed |
| US-20150079191-A1 | CURED GEL AND METHOD OF MAKING | ATRIUM MEDICAL CORPORATION (US) | 2015-03-19 | — | — | US | disclosed |
| US-8962023-B2 | UV cured gel and method of making | ATRIUM MEDICAL CORPORATION (US) | 2015-02-24 | — | — | US | disclosed |
| EP-1819297-B1 | UV CURED GEL AND METHOD OF MAKING | ATRIUM MEDICAL CORP (US) | 2015-01-14 | — | — | EP | disclosed |
| US-20140308333-A1 | COATING MATERIAL AND MEDICAL DEVICE SYSTEM INCLUDING SAME | ATRIUM MEDICAL CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
| US-8858978-B2 | Heat cured gel and method of making | ATRIUM MEDICAL CORPORATION (US) | 2014-10-14 | — | — | US | disclosed |
| US-20140249618-A1 | SITE SPECIFIC DRUG DELIVERY WRAPS, SYSTEMS AND METHODS OF USE THEREOF | ELUTIN, INC. | 2014-09-04 | — | — | US | disclosed |
| US-8821568-B2 | Implant modified with non-hydroxylated vitamin D precursors | NUMAT BIOMEDICAL S.L. (ES) | 2014-09-02 | — | — | US | disclosed |
| WO-2014127278-A2 | SITE SPECIFIC DRUG DELIVERY WRAPS, SYSTEMS AND METHODS OF USE THEREOF | ELUTIN, INC. (US) | 2014-08-21 | — | — | WO | disclosed |
| US-8795703-B2 | Stand-alone film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2014-08-05 | — | — | US | disclosed |
| US-8722077-B2 | Drug delivery coating for use with a stent | ATRIUM MEDICAL CORPORATION (US) | 2014-05-13 | — | — | US | disclosed |
| US-8574618-B2 | Perforated bioabsorbable oil film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2013-11-05 | — | — | US | disclosed |
| US-8574627-B2 | Coated surgical mesh | ATRIUM MEDICAL CORPORATION (US) | 2013-11-05 | — | — | US | disclosed |
| EP-2626091-A1 | Coated surgical mesh | Atrium Medical Corporation (US) | 2013-08-14 | — | — | EP | disclosed |
| US-8501229-B2 | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings | ATRIUM MEDICAL CORPORATION (US) | 2013-08-06 | — | — | US | disclosed |
| US-20130074452-A1 | PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2013-03-28 | — | — | US | disclosed |
| EP-2083875-B1 | COATED SURGICAL MESH | ATRIUM MEDICAL CORP (US) | 2013-03-27 | — | — | EP | disclosed |
| US-8367099-B2 | Perforated fatty acid films | ATRIUM MEDICAL CORPORATION (US) | 2013-02-05 | — | — | US | disclosed |
| US-20130017234-A1 | IMPLANT MODIFIED WITH NON-HYDROXYLATED VITAMIN D PRECURSORS | NUMAT BIOMEDICAL S.L. (ES) | 2013-01-17 | — | — | US | disclosed |
| US-20120315219-A1 | Drug Delivery Coating For Use With A Stent | ATRIUM MEDICAL CORPORATION | 2012-12-13 | — | — | US | disclosed |
| US-8312836-B2 | Method and apparatus for application of a fresh coating on a medical device | ATRIUM MEDICAL CORPORATION (US) | 2012-11-20 | — | — | US | disclosed |
| US-8263102-B2 | Drug delivery coating for use with a stent | ATRIUM MEDICAL CORPORATION (US) | 2012-09-11 | — | — | US | disclosed |
| US-20120213839-A1 | HYDROPHOBIC CROSS-LINKED GELS FOR BIOABSORBABLE DRUG CARRIER COATINGS | ATRIUM MEDICAL CORPORATION | 2012-08-23 | — | — | US | disclosed |
| US-8124127-B2 | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings | ATRIUM MEDICAL CORPORATION (US) | 2012-02-28 | — | — | US | disclosed |
| EP-2348844-A1 | CROSS- LINKED FATTY ACID-BASED BIOMATERIALS | Atrium Medical Corporation (US) | 2011-08-03 | — | — | EP | disclosed |
| EP-2344067-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | Atrium Medical Corporation (US) | 2011-07-20 | — | — | EP | disclosed |
| US-20100233232-A1 | FATTY-ACID BASED PARTICLES | ATRIUM MEDICAL CORPORATION | 2010-09-16 | — | — | US | disclosed |
| WO-2010104790-A2 | FATTY-ACID BASED PARTICLES | ATRIUM MEDICAL CORPORATION (US) | 2010-09-16 | — | — | WO | disclosed |
| WO-2010104786-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | ATRIUM MEDICAL CORPORATION (US) | 2010-09-16 | — | — | WO | disclosed |
| US-20100233231-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | ATRIUM MEDICAL CORPORATION | 2010-09-16 | — | — | US | disclosed |
| EP-2183002-A1 | METHOD AND APPARATUS FOR APPLICATION OF A FRESH COATING ON A MEDICAL DEVICE | Atrium Medical Corporation (US) | 2010-05-12 | — | — | EP | disclosed |
| WO-2010042134-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042241-A1 | CROSS- LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2010-04-15 | — | — | WO | disclosed |
| EP-2136784-A1 | BIO-ABSORBABLE OIL SUSPENSION | Atrium Medical Corporation (US) | 2009-12-30 | — | — | EP | disclosed |
| US-20090208552-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2009-08-20 | — | — | US | disclosed |
| EP-2086605-A2 | PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME | Atrium Medical Corporation (US) | 2009-08-12 | — | — | EP | disclosed |
| EP-2083875-A2 | COATED SURGICAL MESH | Atrium Medical Corporation (US) | 2009-08-05 | — | — | EP | disclosed |
| US-20090181937-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | ATRIUM MEDICAL CORPORATION (US) | 2009-07-16 | — | — | US | disclosed |
| US-20090047414-A1 | METHOD AND APPARATUS FOR APPLICATION OF A FRESH COATING ON A MEDICAL DEVICE | ATRIUM MEDICAL CORPORATION (US) | 2009-02-19 | — | — | US | disclosed |
| WO-2009018325-A1 | METHOD AND APPARATUS FOR APPLICATION OF A FRESH COATING ON A MEDICAL DEVICE | ATRIUM MEDICAL CORPORATION (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008106094-A1 | BIO-ABSORBABLE OIL SUSPENSION | ATRIUM MEDICAL CORPORATION (US) | 2008-09-04 | — | — | WO | disclosed |
| US-20080206305-A1 | drug delivery device: a base surgical mesh structure; an anchoring support element configured to receive an anchoring mechanism; and a barrier layer of cured cross-linked gel derived from fatty acid, fish oil; exhibit antiinflammatory properties, no adhesion, healing | ATRIUM MEDICAL CORPORATION (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080207756-A1 | Bio-absorbable oil suspension | ATRIUM MEDICAL CORPORATION (US) | 2008-08-28 | — | — | US | disclosed |
| WO-2008097418-A2 | BARRIER LAYER WITH UNDERLYING MEDICAL DEVICE AND ONE OR MORE REINFORCING SUPPORT STRUCTURES | ATRIUM MEDICAL CORPORATION (US) | 2008-08-14 | — | — | WO | disclosed |
| EP-1933991-A2 | HYDROPHOBIC CROSS-LINKED GELS FOR BIOABSORBABLE DRUG CARRIER COATINGS | Atrium Medical Corporation (US) | 2008-06-25 | — | — | EP | disclosed |
| US-20080118550-A1 | Coating derived from fish oils that encapsulates the strands while keeping the interstices uncoated, provides antiinflammatory, noninflammatory, and antiadhesion functionality for implantation, is partially cured and contains a therapeutic agent; high biocompatibility | ATRIUM MEDICAL CORPORATION (US) | 2008-05-22 | — | — | US | disclosed |
| WO-2008057344-A2 | COATED SURGICAL MESH | ATRIUM MEDICAL CORPORATION (US) | 2008-05-15 | — | — | WO | disclosed |
| WO-2008057328-A2 | TISSUE SEPARATING DEVICE WITH REINFORCED SUPPORT FOR ANCHORING MECHANISMS | ATRIUM MEDICAL CORPORATION (US) | 2008-05-15 | — | — | WO | disclosed |
| US-20080113001-A1 | Barrier layer device: a base surgical mesh structure; an anchoring support element configured to receive an anchoring mechanism; and a barrier layer of a non-polymeric cross-linked gel | ATRIUM MEDICAL CORPORATION (US) | 2008-05-15 | — | — | US | disclosed |
| US-20080109017-A1 | Barrier layer with underlying medical device and one or more reinforcing support structures | ATRIUM MEDICAL CORPORATION (US) | 2008-05-08 | — | — | US | disclosed |
| WO-2008039308-A2 | PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2008-04-03 | — | — | WO | disclosed |
| US-20070202149-A1 | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings | ATRIUM MEDICAL CORPORATION (US) | 2007-08-30 | — | — | US | disclosed |
| EP-1819297-A2 | UV CURED GEL AND METHOD OF MAKING | Atrium Medical Corporation (US) | 2007-08-22 | — | — | EP | disclosed |
| EP-1811933-A2 | BARRIER LAYER | Atrium Medical Corporation (US) | 2007-08-01 | — | — | EP | disclosed |
| EP-1811935-A2 | HEAT CURED GEL AND METHOD OF MAKING | Atrium Medical Corporation (US) | 2007-08-01 | — | — | EP | disclosed |
| EP-1812022-A2 | STAND-ALONE FILM AND METHODS FOR MAKING THE SAME | Atrium Medical Corporation (US) | 2007-08-01 | — | — | EP | disclosed |
| EP-1804717-A2 | DRUG DELIVERY COATING FOR USE WITH A STENT | Atrium Medical Corporation (US) | 2007-07-11 | — | — | EP | disclosed |
| WO-2007047781-A2 | HYDROPHOBIC CROSS-LINKED GELS FOR BIOABSORBABLE DRUG CARRIER COATINGS | ATRIUM MEDICAL CORPORATION (US) | 2007-04-26 | — | — | WO | disclosed |
| WO-2007047028-A1 | PACKAGING AND STERILIZATION OF MEDICAL DEVICES | ATRIUM MEDICAL CORPORATION (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20070084144-A1 | Packaging and sterilization of medical devices | ATRIUM MEDICAL CORPORATION (US) | 2007-04-19 | — | — | US | disclosed |
| US-20070071798-A1 | Perforated bioabsorbable oil film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2007-03-29 | — | — | US | disclosed |
| WO-2007011385-A2 | HEAT CURED GEL AND METHOD OF MAKING | ATRIUM MEDICAL CORPORATION (US) | 2007-01-25 | — | — | WO | disclosed |
| US-20060110457-A1 | Heat cured gel and method of making | ATRIUM MEDICAL CORPORATION (US) | 2006-05-25 | — | — | US | disclosed |
| US-20060088596-A1 | Solubilizing a drug for use in a coating | ATRIUM MEDICAL CORPORATION (US) | 2006-04-27 | — | — | US | disclosed |
| US-20060083768-A1 | Method of thickening a coating using a drug | ATRIUM MEDICAL CORPORATION (US) | 2006-04-20 | — | — | US | disclosed |
| US-20060078586-A1 | Barrier layer | ATRIUM MEDICAL CORPORATION (US) | 2006-04-13 | — | — | US | disclosed |
| WO-2006036984-A2 | STAND-ALONE FILM AND METHODS FOR MAKING THE SAME | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036969-A2 | FORMATION OF BARRIER LAYER | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036964-A2 | BARRIER LAYER | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036982-A2 | DRUG DELIVERY COATING FOR USE WITH A STENT | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036970-A2 | METHOD OF THICKENING A COATING USING A DRUG | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036967-A1 | SOLUBILIZING A DRUG FOR USE IN A COATING | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006037080-A2 | UV CURED GEL AND METHOD OF MAKING | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006036983-A2 | PRE-DRIED DRUG DELIVERY COATING FOR USE WITH A STENT | ATRIUM MEDICAL CORPORATION (US) | 2006-04-06 | — | — | WO | disclosed |
| US-20060067976-A1 | Formation of barrier layer | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
| US-20060067976-A1 | Formation of barrier layer | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
| US-20060067975-A1 | UV cured gel and method of making | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
| US-20060067974-A1 | Drug delivery coating for use with a stent | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
| US-20060067983-A1 | Stand-alone film and methods for making the same | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
| US-20060067977-A1 | Pre-dried drug delivery coating for use with a stent | ATRIUM MEDICAL CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (19 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120213839-A1 | HYDROPHOBIC CROSS-LINKED GELS FOR BIOABSORBABLE DRUG CARRIER COATINGS | CD44, HDGF, BSG | GSTO1 1136/4885PTPN1 4695/4885LMNA 2623/4885 |
| US-20060067975-A1 | UV cured gel and method of making | PTGES, PTGES2, ALOX5 | GSTO1 331/4885PTPN1 4703/4885LMNA 755/4885 |
| US-20160324816-A1 | FATTY-ACID BASED PARTICLES | FABP4, ELOVL5, ELOVL1 | GSTO1 457/4885PTPN1 4612/4885LMNA 675/4885 |
| US-20090181937-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | FASN, FABP4, FABP7 | GSTO1 412/4885PTPN1 4856/4885LMNA 1001/4885 |
| US-20190054053-A1 | FATTY-ACID BASED PARTICLES | FABP4, ELOVL5, ELOVL1 | GSTO1 457/4885PTPN1 4612/4885LMNA 675/4885 |
| US-11166929-B2 | Fatty-acid based particles | FABP4, ELOVL5, ELOVL1 | GSTO1 457/4885PTPN1 4612/4885LMNA 675/4885 |
| US-10285964-B2 | Fatty-acid based particles | FABP4, ELOVL5, ELOVL1 | GSTO1 457/4885PTPN1 4612/4885LMNA 675/4885 |
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, SHH | GSTO1 1361/4885PTPN1 4848/4885LMNA 2397/4885 |
| US-20090208552-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | FASN, ALOX5, ALOX15B | GSTO1 603/4885PTPN1 4784/4885LMNA 46/4885 |
| US-20100233231-A1 | USE OF CRYOGENIC PROCESSING TO OBTAIN A SUBSTANTIALLY-THICKENED FORMULATION | LIPA, CETP, CPT2 | GSTO1 956/4885PTPN1 4599/4885LMNA 112/4885 |
| US-20180043065-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | FASN, FABP4, FABP7 | GSTO1 412/4885PTPN1 4856/4885LMNA 1001/4885 |
| US-20100233232-A1 | FATTY-ACID BASED PARTICLES | FABP4, ELOVL5, ELOVL1 | GSTO1 457/4885PTPN1 4612/4885LMNA 675/4885 |
| US-20210030928-A1 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | FASN, ALOX5, ALOX15B | GSTO1 603/4885PTPN1 4784/4885LMNA 46/4885 |
| US-20060083768-A1 | Method of thickening a coating using a drug | ABCB1, SLC10A2, ABCB11 | GSTO1 2784/4885PTPN1 4801/4885LMNA 2291/4885 |
| US-20200171213-A9 | CROSS-LINKED FATTY ACID-BASED BIOMATERIALS | FASN, FABP4, FABP7 | GSTO1 412/4885PTPN1 4856/4885LMNA 1001/4885 |
| US-10772995-B2 | Cross-linked fatty acid-based biomaterials | FASN, FABP4, FABP7 | GSTO1 412/4885PTPN1 4856/4885LMNA 1001/4885 |
| US-11793912-B2 | Cross-linked fatty acid-based biomaterials | FASN, ALOX5, ALOX15B | GSTO1 603/4885PTPN1 4784/4885LMNA 46/4885 |
| US-20060088596-A1 | Solubilizing a drug for use in a coating | ABCB11, ABCB1, SLC10A2 | GSTO1 2735/4885PTPN1 4483/4885LMNA 3220/4885 |
| US-10814043-B2 | Cross-linked fatty acid-based biomaterials | FASN, ALOX5, ALOX15B | GSTO1 603/4885PTPN1 4784/4885LMNA 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.